|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chordoma | |||||
| Neuroblastoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Central Nervous System Neoplasms | |||||
| Nervous System Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Nerve Tissue | |||||
| Neoplasms, Neuroepithelial | |||||
| Nervous System Diseases | |||||
| Neuroectodermal Tumors | |||||
| Neuroectodermal Tumors, Primitive | |||||
| Neuroectodermal Tumors, Primitive, Peripheral | |||||
| 4 | Interventions listed in this trial | ||||
| physiologic testing | |||||
| 5 | Sponsors listed in this trial | ||||
| NCI - Center for Cancer Research-Medical Oncology | |||||
| National Cancer Institute (NCI) | |||||